No results were found for your search. Please adjust your search term or broaden your search criteria.
Still can't find what you are looking for? We can prepare Custom Research for you.
Teflaro (ceftaroline fosamil) is an antibiotic used to treat a variety of bacterial infections. It belongs to a class of antibiotics known as cephalosporins, which work by stopping the growth of bacteria. Teflaro is approved for the treatment of skin and skin structure infections, community-acquired bacterial pneumonia, and complicated urinary tract infections. It is also used to treat methicillin-resistant Staphylococcus aureus (MRSA).
Teflaro is available in both intravenous and oral formulations. The intravenous formulation is administered as an infusion over a period of 30 minutes, while the oral formulation is taken as a tablet or capsule. The drug is typically used in combination with other antibiotics to treat more serious infections.
Teflaro is marketed by Allergan, a subsidiary of AbbVie. Other companies that market Teflaro include Merck, Pfizer, and AstraZeneca. Show Less Read more
